BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19500765)

  • 1. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
    Debono M; Ross RJ
    Clin Endocrinol (Oxf); 2013 May; 78(5):659-64. PubMed ID: 23194144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doses and steroids to be used in primary and central hypoadrenalism.
    Debono M; Ross RJ
    Ann Endocrinol (Paris); 2007 Sep; 68(4):265-7. PubMed ID: 17651687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
    Debono M; Ross RJ; Newell-Price J
    Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is physiological glucocorticoid replacement important in children?
    Porter J; Blair J; Ross RJ
    Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G; Falorni A; Skrtic S; Lennernäs H; Quinkler M; Monson JP; Stewart PM
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal glucocorticoid therapy.
    Debono M; Ross RJ
    Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy.
    Chan S; Debono M
    Ther Adv Endocrinol Metab; 2010 Jun; 1(3):129-38. PubMed ID: 23148157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modified-release hydrocortisone for glucocorticoid deficiency].
    Nowotny H; Reisch N
    Internist (Berl); 2020 Jun; 61(6):565-572. PubMed ID: 32394073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is the management of glucocorticoid deficiency still controversial: a review of the literature.
    Crown A; Lightman S
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):483-92. PubMed ID: 16268798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Hydrocortisone Replacement Treatment.
    Mallappa A; Debono M
    Endocr Dev; 2016; 30():42-53. PubMed ID: 26683495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
    Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
    J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future treatment options for adrenal insufficiency.
    Arshad MF; Debono M
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):303-311. PubMed ID: 33782339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.